NO961640L - Stabilt farmasöytisk preparat av terfenadin og ibuprofen - Google Patents

Stabilt farmasöytisk preparat av terfenadin og ibuprofen

Info

Publication number
NO961640L
NO961640L NO961640A NO961640A NO961640L NO 961640 L NO961640 L NO 961640L NO 961640 A NO961640 A NO 961640A NO 961640 A NO961640 A NO 961640A NO 961640 L NO961640 L NO 961640L
Authority
NO
Norway
Prior art keywords
terfenadine
pct
stable pharmaceutical
ibuprofen
pharmaceutical preparation
Prior art date
Application number
NO961640A
Other languages
English (en)
Other versions
NO308773B1 (no
NO961640D0 (no
Inventor
Keith David Ertel
David Francis Long
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO961640D0 publication Critical patent/NO961640D0/no
Publication of NO961640L publication Critical patent/NO961640L/no
Publication of NO308773B1 publication Critical patent/NO308773B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO961640A 1993-10-25 1996-04-24 Stabilt farmasøytisk preparat av terfenadin og ibuprofen NO308773B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14252893A 1993-10-25 1993-10-25
PCT/US1994/010972 WO1995011677A1 (en) 1993-10-25 1994-09-28 A stable pharmaceutical composition of terfenadine and ibuprofen

Publications (3)

Publication Number Publication Date
NO961640D0 NO961640D0 (no) 1996-04-24
NO961640L true NO961640L (no) 1996-04-24
NO308773B1 NO308773B1 (no) 2000-10-30

Family

ID=22500192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961640A NO308773B1 (no) 1993-10-25 1996-04-24 Stabilt farmasøytisk preparat av terfenadin og ibuprofen

Country Status (18)

Country Link
US (1) US5691352A (no)
EP (1) EP0725639B1 (no)
JP (1) JPH09509138A (no)
KR (1) KR100338877B1 (no)
CN (1) CN1060040C (no)
AT (1) ATE197544T1 (no)
AU (1) AU683093B2 (no)
CA (1) CA2173467A1 (no)
DE (1) DE69426306T2 (no)
DK (1) DK0725639T3 (no)
ES (1) ES2153863T3 (no)
FI (1) FI117000B (no)
GR (1) GR3035384T3 (no)
HU (1) HU222887B1 (no)
NO (1) NO308773B1 (no)
NZ (1) NZ274423A (no)
PT (1) PT725639E (no)
WO (1) WO1995011677A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134743B1 (es) * 1998-02-06 2000-05-01 Biocosmetics Sl Composicion para el tratamiento de la halitosis.
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
CN101417131B (zh) * 2007-10-22 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的外用药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
CA2092566A1 (en) * 1990-09-28 1992-03-29 Thomas N. Gates Ibuprofen-antihistamine combinations
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms

Also Published As

Publication number Publication date
US5691352A (en) 1997-11-25
DE69426306T2 (de) 2001-06-07
GR3035384T3 (en) 2001-05-31
KR100338877B1 (ko) 2002-12-05
EP0725639B1 (en) 2000-11-15
DE69426306D1 (de) 2000-12-21
PT725639E (pt) 2001-02-28
EP0725639A1 (en) 1996-08-14
CN1060040C (zh) 2001-01-03
CN1133560A (zh) 1996-10-16
NO308773B1 (no) 2000-10-30
AU7845694A (en) 1995-05-22
WO1995011677A1 (en) 1995-05-04
KR960705565A (ko) 1996-11-08
AU683093B2 (en) 1997-10-30
HUT74577A (en) 1997-01-28
FI117000B (fi) 2006-05-15
FI961756L (fi) 1996-04-24
DK0725639T3 (da) 2000-12-11
NZ274423A (en) 1997-10-24
FI961756A0 (fi) 1996-04-24
JPH09509138A (ja) 1997-09-16
CA2173467A1 (en) 1995-05-04
NO961640D0 (no) 1996-04-24
HU222887B1 (hu) 2003-12-29
HU9601074D0 (en) 1996-06-28
ES2153863T3 (es) 2001-03-16
ATE197544T1 (de) 2000-12-15

Similar Documents

Publication Publication Date Title
ATE167476T1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
EP0985349A3 (en) A method of treating a meat product to reduce a microbial population in the product
NZ292121A (en) 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl derivatives and pharmaceutical compositions thereof
FI981781A7 (fi) Nestemäinen suun kautta käytettävä koostumus, joka sisältää jotakin ka lsiumyhdistettä ja jotakin hapotusainetta
DE59305359D1 (de) Desodorierende kosmetische zubereitungen mit einem gehalt an di- oder triglycerinestern
ATE121932T1 (de) Desodorierende kosmetische mittel.
ATE224920T1 (de) Die verwendung von zinn-katalysatoren sowie vernetzbare mischungen, diese katalysatoren enthaltend
PL298195A1 (en) Sulfonamido- and sulfonabidocabonyl-pyridine-2-carboxylic acid amides and their pyridine-n-oxides, method of obtaining them and their application as therapeutic agents as well therapeutic agents containing them and method of obtaining such therapeutic
FI970298A0 (fi) DHA:n käyttö farmaseuttisena koostumuksena
AU3544693A (en) Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
NO961640L (no) Stabilt farmasöytisk preparat av terfenadin og ibuprofen
AU2979495A (en) Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments
ATE73668T1 (de) Karieshemmung.
EP0649412A4 (en) PYRIDINE PHARMACEUTICAL COMPOUNDS.
UY24780A1 (es) Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación.
TW276983B (no)
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
RU96106811A (ru) Ингибитор кислотной коррозии в нефтепромысловых средах
RU92015628A (ru) Состав для дезинфекции объектов пчеловодства
ES2064577T3 (es) N-azabiciclo(3.3.0)octanoamidas de acidos aromaticos.
FI962301A0 (fi) Substituoidut aminoalkyyliaminopyridiinit
DK0617731T3 (da) N-acyl-phosphatidylethanolamin som oxidationsbeskyttelsesmiddel
MX9200492A (es) 2,4- y 2,5-bis-tetrazolilpiridinas, procedimiento para su preparacion asi como su empleo como medicamentos.
TW246642B (en) Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme

Legal Events

Date Code Title Description
MK1K Patent expired